Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta
Small · 2023
DOI: 10.1002/smll.202303568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2023. Verfasst von Hannah C Safford und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA. Hauptthemen laut MEDLINE: Placenta, Nanoparticles, RNA, Messenger, Lipids. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
During healthy pregnancy, the placenta develops to allow for exchange of nutrients and oxygen between the mother and the fetus. However, placental dysregulation can lead to several pregnancy disorders, such as preeclampsia and fetal growth restriction. Recently, lipid nanoparticle (LNP)‐mediated delivery of messenger RNA (mRNA) has been explored as a promising approach to treat these disorders. Here, iterative libraries of LNPs with varied excipient molar ratios are screened in vitro for enhanced mRNA delivery to placental cells with minimal cytotoxicity when compared to an LNP formulation with a standard excipient molar ratio. LNP C5, the top formulation identified by these screens, demonstrates a fourfold increase in mRNA delivery in vitro compared to the standard formulation. Intravenous administration of LNP C5 to pregnant mice achieves improved in vivo placental mRNA delivery compared to the standard formulation and mediates mRNA delivery to placental trophoblasts, endothelial cells, and immune cells. These results identify LNP C5 as a promising optimized LNP formulation for placental mRNA delivery and further validates the design of experiments strategy for LNP excipient optimization to enhance mRNA delivery to cell types and organs of interest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA.
- Department of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
- Penn Institute for RNA Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
- Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
- Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19014, USA.
ORCID-Profile: Hannah C Safford, Kelsey L Swingle, Hannah C Geisler, Alex G Hamilton, Ajay S Thatte, Margaret M Billingsley, Michael J Mitchell
Förderung
- NIDDK NIH HHS
- NIH HHS
- NCATS NIH HHS
- NCI NIH HHS
- Burroughs Wellcome Fund
- National Science Foundation CAREER award
- NSF Graduate Research Fellowships
- National Institutes of Health
Zitieren
APA
Safford, H. C., Swingle, K. L., Geisler, H. C., Hamilton, A. G., Thatte, A. S., Ghalsasi, A. A., Billingsley, M. M., Alameh, M. G., Weissman, D., & Mitchell, M. J. (2023). Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta. Small. https://doi.org/10.1002/smll.202303568
Vancouver
Safford HC, Swingle KL, Geisler HC, Hamilton AG, Thatte AS, Ghalsasi AA, et al. Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta. Small. 2023. doi:10.1002/smll.202303568
BibTeX
@article{Safford2023,
author = {Safford, Hannah C and Swingle, Kelsey L and Geisler, Hannah C and Hamilton, Alex G and Thatte, Ajay S and Ghalsasi, Aditi A and Billingsley, Margaret M and Alameh, Mohamad-Gabriel and Weissman, Drew and Mitchell, Michael J},
title = {Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta},
journal = {Small},
year = {2023},
doi = {10.1002/smll.202303568}
}
EUVIMED